Glibenclamide / Metformin Sales, Price Analysis, & Sales Forecast - 2017 - Research and Markets
April 21 2017 - 7:40AM
Business Wire
Research and Markets has announced the addition of the
"Glibenclamide / Metformin Sales, Price Analysis, & Sales
Forecast - 2017" report to their offering.
Introducing the new research, Glibenclamide / Metformin Sales,
Price Analysis, & Sales Forecast - 2017.
Find out the sales of Glibenclamide / Metformin worldwide and by
countries in North America, Europe, Japan, BRIC, and Australia.
Discover the growth trends of Glibenclamide / Metformin by
countries, and also find out sales forecast until 2021.
The research also provides Glibenclamide / Metformin unit price
by countries. The sales and price data from this report is useful
for analyzing Glibenclamide / Metformin sales trends, sales
forecast for Glibenclamide / Metformin, brand planning,
Glibenclamide / Metformin generics trends, product positioning,
strategic forecasts, BD&L, competitive intelligence, pricing
analysis, and price benchmarks.
Research Scope:
- Product: Glibenclamide / Metformin
- Country Scope: US, Germany, France, Italy, Spain, UK, Japan,
Brazil, Russia, India, China, Canada, and Australia
- Companies marketing Glibenclamide / Metformin and by brand name
in major countries
- Historic Glibenclamide / Metformin sales revenues ($mn)
worldwide and by countries, sales trends
- Glibenclamide / Metformin unit price by countries, trends, and
benchmarks
- Glibenclamide / Metformin sales forecast ($mn) worldwide and by
countries
Benefits to the User
- Identify companies marketing Glibenclamide / Metformin by major
countries
- Find out Glibenclamide / Metformin sales, growth, and sales
forecast by major countries; Use it for your market planning -
market assessments, market sizing, market shares, BD&L, product
strategy, positioning, and competitive intelligence
- Determine the price of Glibenclamide / Metformin in major
markets; Use it to devise pricing strategies, estimate patient
shares, develop patient forecast models, and estimate annual
therapy costs
- Derive unit sales of Glibenclamide / Metformin by countries
using pricing and sales data; Use it for your market planning -
market assessments, market sizing, market shares, BD&L, product
strategy, positioning, and competitive intelligence
Key Topics Covered:
1. Glibenclamide / Metformin - Introduction
2. Glibenclamide / Metformin Sales Analysis
3. Glibenclamide / Metformin Sales by Countries
4. Glibenclamide / Metformin Price Analysis by Countries
5. Glibenclamide / Metformin Sales Forecast
6. Glibenclamide / Metformin Sales Forecast by Countries
7. Methodology
For more information about this report visit
http://www.researchandmarkets.com/research/nnc9tl/glibenclamide
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170421005301/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Related Topics: Endocrine and Metabolic
Disorders Drugs, Drugs by Therapeutic Area